Skip to main content
OpenTrials

Clinical trial condition

Neurotoxicity Syndromes

Explore clinical trials studying Neurotoxicity Syndromes. Study availability and eligibility vary by location and protocol.

94 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Neurotoxicity Syndromes trial results

Completed

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

NCT00046891

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Santa Barbara Hematology Oncology - Lompoc Lompoc, California, United States
  • Sansum Medical Clinic Santa Barbara, California, United States
  • Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara Santa Barbara, California, United States
View all 175 locations
View Trial Details
Completed

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

NCT00027963

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurologic Manifestations, +6 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 23 locations
View Trial Details
Completed

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

NCT00305188

Conditions
Chemically-Induced Disorders, Colonic Diseases, Colorectal Carcinoma, +23 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Macquarie Park, Australia
  • Sanofi-Aventis Administrative Office São Paulo, Brazil
View all 13 locations
View Trial Details
Completed

Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer

NCT01763710

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Hospital Universitario Del Sureste Arganda, Madrid, Spain
  • Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain
  • Hospital Universitario de Getafe Getafe, Madrid, Spain
  • Hospital Universitario Severo Ochoa Leganés, Madrid, Spain
View Trial Details
Completed

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

NCT00471445

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurologic Manifestations, +10 more
Locations
  • MBCCOP - Hawaii Honolulu, Hawaii, United States
  • MBCCOP - University of Illinois at Chicago Chicago, Illinois, United States
  • CCOP - Central Illinois Decatur, Illinois, United States
  • CCOP - Evanston Evanston, Illinois, United States
View all 17 locations
View Trial Details
Completed

Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

NCT00018967

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +4 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 103 locations
View Trial Details
Completed

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

NCT01417507

Conditions
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, +22 more
Locations
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
View all 41 locations
View Trial Details
Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions
Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Riverside Methodist Hospital Columbus, Ohio, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

NCT00666484

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • University College Hospital - London London, England, United Kingdom
  • King's College Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details

Related conditions